» Articles » PMID: 24474437

Prevalence and Presentation of Hepatitis B and C Virus (HBV and HCV) Infection in Vietnamese Americans Via Serial Community Serologic Testing

Overview
Publisher Springer
Date 2014 Jan 30
PMID 24474437
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of hepatitis B virus (HBV) infection is reportedly high in Vietnamese Americans (VAs), but most previous studies did not assess full HBV serology, and not the prevalence of HBV and hepatitis C virus (HCV) infection simultaneously. The aim of the study is to assess the prevalence of different HBV serologies and HCV infection in VAs. This study was based on the data collected by testing for Hepatitis B surface antigen (HBsAg), anti-hepatitis B core antibody (HBcAb IgG), anti-HBs antibody (HBsAb), and anti-HCV antibody (anti-HCV) in a series of community screening in VAs in Orange County, California. In 1,405 VA participants, the mean age was 51 (17-87) years, 45.1% were males; 68.2%, married; 97.2%, born in Vietnam. Most of the participants were non-US born with their primary language being non-English and with limited access to health care. Of the 1,405 cases, 124 (8.8%) were confirmed HBV infection by HBsAg+; 81 (5.8%), HCV infection by anti-HCV+; including four (0.3%) with HBV/HCV coinfection. Twelve percent of the participants with confirmed HBV infection thought they were previously tested negative, while 29.7% of the participants with confirmed HCV infection thought they were previously tested negative. In this cohort, 15.4% were HBsAg-/HBsAb-/HBcAb IgG-, i.e. being susceptible to HBV infection. In HCV infected participants, 65.4% were born between 1945 and 1965. This large serial survey and screening in the Vietnamese American community confirmed the rates of HBV and HCV infection to be as high as 8.8% and 5.8%, respectively. We have also identified factors related to HBV and HCV infection in this high-risk population.

Citing Articles

Assessing the Feasibility, Acceptability, and Effectiveness of a Pilot Hepatitis C Screening Program at Food Distribution Sites in Cherokee Nation, Oklahoma.

Essex W, Mera J, Comiford A, Winters A, Feder M J Community Health. 2023; 48(6):982-993.

PMID: 37531046 PMC: 10558369. DOI: 10.1007/s10900-023-01264-y.


A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus.

Ma G, Zhu L, Tan Y, Zhai S, Ma X, Ogunwobi O Dig Dis Sci. 2023; 68(6):2333-2343.

PMID: 36749506 PMC: 10192107. DOI: 10.1007/s10620-023-07840-5.


Efficacy of a Primary Care-Based Mobile Application to Increase Hepatitis C Screening Among Asian Americans: A Secondary Analysis of a Randomized Clinical Trial.

Khalili M, Kim N, Tsoh J, Walsh J, Elizabeth Goldman L, Park H Open Forum Infect Dis. 2023; 10(1):ofad002.

PMID: 36726551 PMC: 9887262. DOI: 10.1093/ofid/ofad002.


Reducing Liver Cancer Risk through Dietary Change: Positive Results from a Community-Based Educational Initiative in Three Racial/Ethnic Groups.

Zhu L, Kim E, Gonzalez E, Fraser M, Zhu S, Rubio-Torio N Nutrients. 2022; 14(22).

PMID: 36432564 PMC: 9698707. DOI: 10.3390/nu14224878.


Sociodemographic characteristics associated with hepatitis C virus infection in Vietnamese Americans: A cross-sectional analysis of community screening data.

Lee A, Jacobs W, Tran M, Nguyen B, Hua D, Ho J PLoS One. 2022; 17(9):e0275210.

PMID: 36166444 PMC: 9514619. DOI: 10.1371/journal.pone.0275210.


References
1.
Beasley R, Hwang L, Lin C, Chien C . Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256):1129-33. DOI: 10.1016/s0140-6736(81)90585-7. View

2.
Kowdley K, Wang C, Welch S, Roberts H, Brosgart C . Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2011; 56(2):422-33. DOI: 10.1002/hep.24804. View

3.
Lok A, McMahon B . Chronic hepatitis B: update 2009. Hepatology. 2009; 50(3):661-2. DOI: 10.1002/hep.23190. View

4.
Johnson P . The epidemiology of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 1996; 8(9):845-9. View

5.
Yu M, Chuang W . Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol. 2009; 24(3):336-45. DOI: 10.1111/j.1440-1746.2009.05789.x. View